WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1'4801 Infant (under 12 months) mortality rate: 562
GDP / capita (US$): 3'1811 Child (under 5 years) mortality rate: 882

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 14'539  14'075  13'634  13'217  12'825  10'101  7'845  5'847 
Births 625  608  591  575  559  459  344  271 
Surviving infants 585  568  550  534  518  412  305  244 
Pop. less than 5 years 2'656  2'566  2'484  2'417  2'349  1'866  1'397  1'123 
Pop. less than 15 years 6'777  6'575  6'382  6'200  6'018  4'619  3'601  2'771 
Female 15-49 years 3'336  3'217  3'104  2'997  2'902  2'311  1'775  1'273 

Number of reported case

(Click for retrospective incidence data for Zambia)
Diphtheria 12 
Japanese encephalitis
Measles 35  896  13'234  15'754  26  30'930  6'748  98'659 
Mumps 6'213 
Pertussis 681  200  21'232 
Polio* 79  276 
Rubella 183  134  1'124  13 
Rubella (CRS)
Tetanus (neonatal) 130  57 
Tetanus (total) 193  57  409 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Zambia)
Vaccine year result method % card seen                                                
BCG 2010  98  EPI   77  82  83  88  93  99*  100  97 
DTP1 2010  98  EPI   77  86  86  87  92  98  93 
DTP3 2010  93  EPI   77  79  78  81  84  98  76  71 
HepB_BD         
HepB3 2010  93  EPI   77  79  78  81  84  98 
Hib3 2010  93  EPI   77  79  78  81  84  98 
JapEnc         
MCV 2010  90  EPI   77  80  95  83  97  92  85  68 
MCV2         
PCV1         
PCV3         
Pol3 2010  90  EPI   77  74  70  83  81  96  79  70 
Rota1         
Rota_last         
Rubella1         
TT2plus 2001  27  DHS   80  74  71  74  72  71  61 
PAB         
VAD1          100  59  99*  90 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Zambia)
BCG 82  83  88  92  92  94  97 
DTP1 86  86  87  92  96  94  97 
DTP3 79  78  81  83  94  85  91 
HepB3 79  78  81  83  94 
HepB_BD
Hib3 79  78  81  83  94 
MCV 80  82  83  96  90  85  90 
MCV2
PAB 81  81  81  90  90  78  62 
PCV3
Pol3 74  70  83  80  93  85  90 
Rota_last

Number of districts in the country 74  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 35
From 80 to 89% 18
From 50 to 79% 42
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV 6, 10, 14 weeks; Yes
TT 1st contact pregnancy; +1, +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12, 18, 24, 30, 36 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2011-2015  2011-2015  2011-2015  2010 - 2014  2006-2010  2006-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 105  72  72  72  72    70 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

System performance

Total Nº districts in country number 74  72  72  72  72  72  72 
Nº districts with DTP3 coverage >=80% number 39  50  45  49  62  55  19 
% of districts with DTP3 coverage >=80% From 0 to 100% 53  69  63  68  86  76  26 
Nº districts with measles (MCV1) coverage >=95% number 15  37  25  42  32  23   
% of districts with MCV1 coverage >=95% From 0 to 100% 20  51  35  58  44  32   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes    Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes    Yes  Yes  Yes    Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 29    29  19  95  73  24 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.